Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00027378 · ClinicalTrials.gov registry record · Phase 2
Pharmacological Intervention Project (Fluoxetine)
A Phase 2 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00027378: Completed Phase 2 study, sponsored by University of Pittsburgh.
NCT00027378 is a Phase 2 study that has completed, run by University of Pittsburgh. The registered enrollment target is 50 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00027378, a Phase 2 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a large scale study involving fluoxetine (Prozac) versus a placebo in the treatment of adolescents with alcohol use disorder (AUD) and major depression (MDD). All individuals will receive treatment for 12 weeks with a followup phase lasting 9 months.
Primary Outcome
Alcohol use behaviors measured by drinks per week.
Interventions
- DRUG fluoxetine (Prozac)
- DRUG Placebo plus Treatment As Usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2001-07 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
What the finished NCT00027378 record still lists
NCT00027378 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 2 interventions - of which fluoxetine (Prozac) is the first listed.
NCT00027378 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00027378 about?
NCT00027378 is a clinical study titled "Pharmacological Intervention Project (Fluoxetine)". This is a large scale study involving fluoxetine (Prozac) versus a placebo in the treatment of adolescents with alcohol use disorder (AUD) and major depression (MDD). All individuals will receive treatment for 12 weeks with a followup phase lasting 9 months.
What is the current status of trial NCT00027378?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2001-07. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00027378?
The interventions under investigation include: fluoxetine (Prozac) (DRUG), Placebo plus Treatment As Usual (DRUG).
Who is sponsoring clinical trial NCT00027378?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00027378's enrollment target sits among peer trials
50 1195th of 2000 higher than 740 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia